[HTML][HTML] Маркеры эндотелиальной дисфункции: патогенетическая роль и диагностическое значение (обзор литературы)
ТВ Степанова, АН Иванов, НЕ Терешкина… - Клиническая …, 2019 - cyberleninka.ru
Эндотелиальная дисфункция (ЭД) считается одним из патогенетических механизмов
целого спектра заболеваний. Эффективным способом диагностики ЭД является …
целого спектра заболеваний. Эффективным способом диагностики ЭД является …
Endogenous antiangiogenic factors in chronic kidney disease: potential biomarkers of progression
K Tanabe, Y Sato, J Wada - International journal of molecular sciences, 2018 - mdpi.com
Chronic kidney disease (CKD) is a major global health problem. Unless intensive
intervention is initiated, some patients can rapidly progress to end-stage kidney disease …
intervention is initiated, some patients can rapidly progress to end-stage kidney disease …
Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis
B Van der Veken, GRY De Meyer… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Atherosclerosis is a lipid-driven inflammatory process with a tremendously high
mortality due to acute cardiac events. There is an emerging need for new therapies to …
mortality due to acute cardiac events. There is an emerging need for new therapies to …
Soluble vascular cell adhesion molecules may be protective of future cardiovascular disease risk: findings from the PREVEND prospective cohort study
SK Kunutsor, SJL Bakker, RPF Dullaart - Journal of atherosclerosis …, 2017 - jstage.jst.go.jp
Aim: Soluble cell adhesion molecules, such as vascular cell adhesion molecule-1 (VCAM-
1), intercellular adhesion molecule-1, E-selectin, and P-selectin, have been suggested to be …
1), intercellular adhesion molecule-1, E-selectin, and P-selectin, have been suggested to be …
Endothelial dysfunction: developmental mechanisms and therapeutic strategies
DV Shcheblykin, AA Bolgov… - Research Results in …, 2022 - rrpharmacology.ru
Endothelial dysfunction: developmental mechanisms and therapeutic strategies Page 1
Endothelial dysfunction: developmental mechanisms and therapeutic strategies Dmitry V …
Endothelial dysfunction: developmental mechanisms and therapeutic strategies Dmitry V …
Pathological Study on the Expression of Vasohibins in Peripheral Artery Disease
R Isoda, I Morita, A Ishida, Y Mikami… - The Tohoku Journal of …, 2022 - jstage.jst.go.jp
Abstract Vasohibin-2 (VASH2) is a gene that promotes local angiogenesis. The tubulin
carboxypeptidase activity of vasohibin causes detyrosination of alpha-tubulin and may play …
carboxypeptidase activity of vasohibin causes detyrosination of alpha-tubulin and may play …
Experimental Study on the Effects of Melatonin Supplementation on Obesity-Induced Endothelial Dysfunction
DL Chivchibashi - 2022 - search.proquest.com
Obesity is a medical and social problem due to associated comorbidities. It is believed that
endothelial dysfunction (ED) links the latter with obesity and triggers the development of …
endothelial dysfunction (ED) links the latter with obesity and triggers the development of …
Can vasohibin‐1, an endothelium‐derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?
O Altunoren, M Kerkutluoglu, FN Sarısık… - Seminars in …, 2020 - Wiley Online Library
Background Endothelial dysfunction (ED) is associated with high cardiovascular disease
burden in hemodialysis (HD) patients. Vasohibin‐1, an endothelium‐derived angiogenesis …
burden in hemodialysis (HD) patients. Vasohibin‐1, an endothelium‐derived angiogenesis …
Methods and pharmaceutical compositions for treating tubulin carboxypeptidases associated diseases
A Andrieux, M Moutin, C Bosc, C Aillaud… - US Patent …, 2023 - Google Patents
2020-10-01 Assigned to LES LABORATOIRES SERVIER, INSERM (INSTITUT NATIONAL
DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE GRENOBLE ALPES …
DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE GRENOBLE ALPES …